• Home
  • Pharmaceuticals and Healthcare
Group B Streptococcus (GBS) Infection Treatment Market - Global Outlook and Forecast 2021-2027

Group B Streptococcus (GBS) Infection Treatment Market - Global Outlook and Forecast 2021-2027

Report Code: KNJ687408 | No. of Pages: 92 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2021 
This report contains market size and forecasts of Group B Streptococcus (GBS) Infection Treatment in Global, including the following market information:
Global Group B Streptococcus (GBS) Infection Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Group B Streptococcus (GBS) Infection Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Group B Streptococcus (GBS) Infection Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Group B Streptococcus (GBS) Infection Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Type, 2020 (%)
Prenatal-onset Gbs Disease
Early-onset Gbs Disease
Late-onset Gbs Disease

China Group B Streptococcus (GBS) Infection Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Group B Streptococcus (GBS) Infection Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Group B Streptococcus (GBS) Infection Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Group B Streptococcus (GBS) Infection Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Group B Streptococcus (GBS) Infection Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Pfizer Inc.
Alopexx Enterprises, LLC
Wellstat Vaccines LLC
Minervax ApS
Novartis
GlaxoSmithKline
1 Introduction to Research & Analysis Reports
    1.1 Group B Streptococcus (GBS) Infection Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Group B Streptococcus (GBS) Infection Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Group B Streptococcus (GBS) Infection Treatment Overall Market Size
    2.1 Global Group B Streptococcus (GBS) Infection Treatment Market Size: 2021 VS 2027
    2.2 Global Group B Streptococcus (GBS) Infection Treatment Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Group B Streptococcus (GBS) Infection Treatment Players in Global Market
    3.2 Top Global Group B Streptococcus (GBS) Infection Treatment Companies Ranked by Revenue
    3.3 Global Group B Streptococcus (GBS) Infection Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Group B Streptococcus (GBS) Infection Treatment Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Group B Streptococcus (GBS) Infection Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Group B Streptococcus (GBS) Infection Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Group B Streptococcus (GBS) Infection Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Group B Streptococcus (GBS) Infection Treatment Market Size Markets, 2021 & 2027
        4.1.2 Prenatal-onset Gbs Disease
        4.1.3 Early-onset Gbs Disease
        4.1.4 Late-onset Gbs Disease
    4.2 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
        4.2.1 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2021
        4.2.2 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2022-2027
        4.2.3 By Type - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Group B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2027
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
        5.2.1 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2021
        5.2.2 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2022-2027
        5.2.3 By Application - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Group B Streptococcus (GBS) Infection Treatment Market Size, 2021 & 2027
    6.2 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue & Forecasts
        6.2.1 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2021
        6.2.2 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue, 2022-2027
        6.2.3 By Region - Global Group B Streptococcus (GBS) Infection Treatment Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
        6.3.2 US Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.3.3 Canada Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.3.4 Mexico Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
        6.4.2 Germany Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.4.3 France Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.4.4 U.K. Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.4.5 Italy Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.4.6 Russia Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.4.7 Nordic Countries Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.4.8 Benelux Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
        6.5.2 China Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.5.3 Japan Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.5.4 South Korea Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.5.5 Southeast Asia Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.5.6 India Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
        6.6.2 Brazil Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.6.3 Argentina Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Group B Streptococcus (GBS) Infection Treatment Revenue, 2016-2027
        6.7.2 Turkey Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.7.3 Israel Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.7.4 Saudi Arabia Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
        6.7.5 UAE Group B Streptococcus (GBS) Infection Treatment Market Size, 2016-2027
7 Players Profiles
    7.1 Pfizer Inc.
        7.1.1 Pfizer Inc. Corporate Summary
        7.1.2 Pfizer Inc. Business Overview
        7.1.3 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
        7.1.4 Pfizer Inc. Group B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
        7.1.5 Pfizer Inc. Key News
    7.2 Alopexx Enterprises, LLC
        7.2.1 Alopexx Enterprises, LLC Corporate Summary
        7.2.2 Alopexx Enterprises, LLC Business Overview
        7.2.3 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
        7.2.4 Alopexx Enterprises, LLC Group B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
        7.2.5 Alopexx Enterprises, LLC Key News
    7.3 Wellstat Vaccines LLC
        7.3.1 Wellstat Vaccines LLC Corporate Summary
        7.3.2 Wellstat Vaccines LLC Business Overview
        7.3.3 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
        7.3.4 Wellstat Vaccines LLC Group B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
        7.3.5 Wellstat Vaccines LLC Key News
    7.4 Minervax ApS
        7.4.1 Minervax ApS Corporate Summary
        7.4.2 Minervax ApS Business Overview
        7.4.3 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
        7.4.4 Minervax ApS Group B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
        7.4.5 Minervax ApS Key News
    7.5 Novartis
        7.5.1 Novartis Corporate Summary
        7.5.2 Novartis Business Overview
        7.5.3 Novartis Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
        7.5.4 Novartis Group B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
        7.5.5 Novartis Key News
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Corporate Summary
        7.6.2 GlaxoSmithKline Business Overview
        7.6.3 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Major Product Offerings
        7.6.4 GlaxoSmithKline Group B Streptococcus (GBS) Infection Treatment Revenue in Global (2016-2021)
        7.6.5 GlaxoSmithKline Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer


List of Tables and Figures
Ask Sample Report to get more details…

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com